{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:27:06Z","timestamp":1788985626594,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003075","name":"Chongqing Municipal Public Health Bureau, Chongqing People's Municipal Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is associated with progressive cognitive decline, functional impairment, and reduced quality of life. Although pharmacological treatments such as cholinesterase inhibitors and memantine are commonly used, their clinical benefits remain limited and heterogeneous. Cognitive stimulation therapy (CST) may provide additional benefits when combined with standard pharmacotherapy. This randomized controlled trial (RCT) aimed to evaluate the clinical efficacy of modified CST combined with standard drug therapy on cognitive function, activities of daily living, and quality of life in patients with mild-to-moderate AD and to explore key predictors of CST efficacy using a multivariate regression model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This evaluator-blinded randomized controlled trial enrolled 80 patients with mild-to-moderate Alzheimer\u2019s disease (AD), who were randomly assigned in a 1:1 ratio to either the modified CST plus standard pharmacotherapy group (study group, n = 40) or the standard pharmacotherapy-alone group (control group, n = 40).The modified CST program comprised 14 weekly 45-minute sessions. The primary endpoint was the change in the Alzheimer\u2019s Disease Assessment Scale\u2013Cognitive Subscale (ADAS-Cog) score from baseline to post-intervention. Secondary measures included the Activities of Daily Living (ADL) scale and the Quality of Life in Alzheimer\u2019s disease (QOL-AD) questionnaire. Data were analyzed using an intention-to-treat (ITT) approach. Independent predictors of treatment efficacy were identified using a two-stage screening strategy (univariate screening and stepwise regression).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 75 patients completed the study, and 80 were included in the ITT analysis. After 14 weeks of intervention, baseline-adjusted ANCOVA showed that the study group had significantly better post-intervention ADAS-Cog scores than the control group. The adjusted mean difference in ADAS-Cog score was -3.28 points (95% CI: -3.72 to -2.83; P &amp;lt; 0.001), favoring the study group. Significant baseline-adjusted between-group differences were also observed for ADL (adjusted mean difference = -4.93, 95% CI: -8.39 to -1.47; P\u00a0=\u00a00.006) and QOL-AD (adjusted mean difference = 2.69, 95% CI: 1.01 to 4.37; P\u00a0=\u00a00.002), both favoring the study group. Higher years of education (\u03b2 = -0.54, P &amp;lt; 0.001), regular physical activity (\u03b2 = -0.28, P\u00a0=\u00a00.003), higher baseline Mini-Mental State Examination (MMSE) scores (\u03b2 = -0.22, P\u00a0=\u00a00.001), and active hobbies (\u03b2 = -0.20, P\u00a0=\u00a00.002) were significant independent predictors of CST efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Modified CST combined with medication significantly delays cognitive decline and improves QOL-AD in patients with mild-to-moderate AD. Educational attainment, lifestyle factors, and cognitive reserve are key determinants of CST efficacy. Relevant institutions should develop targeted enhancement protocols for patients with lower educational levels or insufficient cognitive reserves when implementing CST.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      Chinese Clinical Trial Registry, identifier ChiCTR2600118654,\n                      <jats:ext-link>https:\/\/www.chictr.org.cn<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1840039","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:45:14Z","timestamp":1782452714000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and predictors of cognitive stimulation therapy combined with pharmacotherapy for mild-to-moderate Alzheimer\u2019s disease: a randomized controlled trial"],"prefix":"10.3389","volume":"17","author":[{"given":"Li","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Chongqing Mental Health Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Chongqing Mental Health Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Chongqing Mental Health Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Chongqing Mental Health Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Chongqing Mental Health Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Chongqing Mental Health Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019","volume":"14","author":"Li","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13144100","article-title":"Charting Alzheimer's disease and dementia: epidemiological insights, risk factors and prevention pathways","volume":"13","author":"Contador","year":"2024","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30185-7","article-title":"Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study","volume":"5","author":"Jia","year":"2020","journal-title":"Lancet Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037799","article-title":"Evaluating the efficacy and safety of Alzheimer's disease drugs: a meta-analysis and systematic review","volume":"103","author":"Chen","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/13872877241292829","article-title":"A systematic review of lifestyle-based interventions for managing Alzheimer's disease: insights from randomized controlled trials","volume":"102","author":"Martinez-Lopez","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/gps.2464","article-title":"Cognitive stimulation therapy (CST): effects on different areas of cognitive function for people with dementia","volume":"25","author":"Spector","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/07317115.2020.1821857","article-title":"Cultural adaptation of cognitive stimulation therapy (CST) for Portuguese people with dementia","volume":"45","author":"Pereira","year":"2022","journal-title":"Clin Gerontol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/gps.70109","article-title":"Cognitive stimulation therapy-Spain (CST-ES): cultural adaptation process and pilot study","volume":"40","author":"Perez-Saez","year":"2025","journal-title":"Int J Geriatr Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1037\/neu0000965","article-title":"Nonpharmacological treatment for older adults with mild cognitive impairment: considerations for culturally informed clinical practice and research","volume":"38","author":"Azar","year":"2024","journal-title":"Neuropsychology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijchp.2024.100510","article-title":"Does cognitive stimulation therapy show similar efficacy in individuals with mild-to-moderate dementia from varying etiologies? An examination comparing its effectiveness in Alzheimer's disease and vascular dementia","volume":"24","author":"Piras","year":"2024","journal-title":"Int J Clin Health Psychol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00494-5","article-title":"A multicentre, randomised, open-label, prospective study to estimate the add-on effects of memantine as Ebixa oral pump solution on language in patients with moderate to severe Alzheimer's disease already receiving donepezil: ROMEO-AD","volume":"12","author":"Kim","year":"2023","journal-title":"Neurol Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/07317115.2023.2203139","article-title":"Cognitive stimulation therapy in a veteran sample: a program evaluation study","volume":"48","author":"Peak","year":"2025","journal-title":"Clin Gerontol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.14283\/jpad.2018.2","article-title":"Detecting treatment group differences in Alzheimer's disease clinical trials: a comparison of Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Clinical Dementia Rating-Sum of Boxes","volume":"5","author":"Wessels","year":"2018","journal-title":"J Prev Alzheimers Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12955-020-01554-2","article-title":"Quality of life and factors affecting it in patients with Alzheimer's disease: a cross-sectional study","volume":"18","author":"Akpinar Soylemez","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/geront\/gnac057","article-title":"Assessing patterns and stability of ADL hierarchical scales for functional disability assessment","volume":"63","author":"Fong","year":"2022","journal-title":"Gerontologist"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/1533317520918719","article-title":"Longitudinal sensitivity of Alzheimer's disease severity staging","volume":"35","author":"Benoit","year":"2020","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1208802","article-title":"Exploring the relationship between patient-relevant outcomes and Alzheimer's disease progression assessed using the Clinical Dementia Rating scale: a systematic literature review","volume":"14","author":"Cummings","year":"2023","journal-title":"Front Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3352\/jeehp.2021.18.17","article-title":"Sample size determination and power analysis using the G*Power software","volume":"18","author":"Kang","year":"2021","journal-title":"J Educ Eval Health Prof"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/geronb\/gbab007","article-title":"Cognitive stimulation therapy (CST) for older adults with mild-to-moderate dementia in Italy: effects on cognitive functioning and on emotional and neuropsychiatric symptoms","volume":"26","author":"Carbone","year":"2021","journal-title":"journals gerontol Ser B psychol Sci Soc Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18051\/univmed.2024.v43.13-19","article-title":"Effect of cognitive stimulation therapy in combination with other intervention modalities on cognitive ability in elderly with cognitive impairment: a quasi-experimental study","volume":"43","author":"Turana","year":"2024","journal-title":"Univ Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13486","article-title":"A multidomain intervention against cognitive decline in an at-risk population in Germany: results from the cluster-randomized AgeWell.de trial","volume":"20","author":"Zulke","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B23","doi-asserted-by":"publisher","first-page":"102312","DOI":"10.1016\/j.arr.2024.102312","article-title":"Effectiveness of cognitive stimulation therapy (CST) for mild to moderate dementia: a systematic literature review and meta-analysis of randomised control trials using the original CST protocol","volume":"97","author":"Desai","year":"2024","journal-title":"Ageing Res Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103438","article-title":"Improving anti-neurodegenerative benefits of acetylcholinesterase inhibitors in Alzheimer's disease: are irreversible inhibitors the future","volume":"21","author":"Moss","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1590\/1980-5764-dn-2022-s106pt","article-title":"Treatment of dementia: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology","volume":"16","author":"Caramelli","year":"2022","journal-title":"Dement Neuropsychol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.29057\/mjmr.v13i25.12429","article-title":"Pharmacological and non-pharmacological treatments for cognitive impairments in older adults with Alzheimer's disease: a narrative review","volume":"13","author":"Moreno-Vargas","year":"2025","journal-title":"Mex J Med Res ICSA"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.115937","article-title":"Social isolation and subsequent health and well-being in older adults: a longitudinal outcome-wide analysis","volume":"327","author":"Nakagomi","year":"2023","journal-title":"Soc Sci Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.811127","article-title":"The role of individual characteristics in predicting short- and long-term cognitive and psychological benefits of cognitive stimulation therapy for mild-to-moderate dementia","volume":"13","author":"Carbone","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14236","article-title":"Factors associated with cognitive reserve according to education level","volume":"20","author":"Kim","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1017\/S204579602100069X","article-title":"The role of cognitive and social leisure activities in dementia risk: assessing longitudinal associations of modifiable and non-modifiable risk factors","volume":"31","author":"Duffner","year":"2022","journal-title":"Epidemiol Psychiatr Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S435464","article-title":"Lifestyle influence on mild cognitive impairment progression: a decision tree prediction model study","volume":"20","author":"Hou","year":"2024","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.gerinurse.2024.02.012","article-title":"Pilot testing cognitive stimulation intervention on older adults' cognitive function, cognitive self-efficacy, and sense of happiness","volume":"56","author":"AbdElsalam","year":"2024","journal-title":"Geriatr Nurs"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20217027","article-title":"Improving sleep quality, daytime sleepiness, and cognitive function in patients with dementia by therapeutic physical activity and NESA neuromodulation: a multicenter clinical trial","volume":"20","author":"Teruel-Hernandez","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-025-00935-x","article-title":"Aerobic exercise training improves learning and memory performance in hypoxic-exposed rats by activating the hippocampal PKA-CREB-BDNF signaling pathway","volume":"26","author":"Luo","year":"2025","journal-title":"BMC Neurosci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1605970","article-title":"An integrated multifocal tDCS-EEG protocol for reducing cognitive and affective symptoms in mild cognitive impairment and early stages of dementia: a crossover double-blind randomized controlled trial","volume":"16","author":"Catalano","year":"2025","journal-title":"Front Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11091137","article-title":"Changes in Default Mode Network connectivity in resting-state fMRI in people with mild dementia receiving cognitive stimulation therapy","volume":"11","author":"Liu","year":"2021","journal-title":"Brain Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2025.101062","article-title":"An inflammatory fingerprint in mild cognitively impaired patients is reversed by physical and cognitive training","volume":"48","author":"Desiato","year":"2025","journal-title":"Brain Behav Immun Health"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1840039\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:45:15Z","timestamp":1782452715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1840039\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":37,"alternative-id":["10.3389\/fpsyt.2026.1840039"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1840039","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1840039"}}